JP2021518405A5 - - Google Patents

Info

Publication number
JP2021518405A5
JP2021518405A5 JP2020550751A JP2020550751A JP2021518405A5 JP 2021518405 A5 JP2021518405 A5 JP 2021518405A5 JP 2020550751 A JP2020550751 A JP 2020550751A JP 2020550751 A JP2020550751 A JP 2020550751A JP 2021518405 A5 JP2021518405 A5 JP 2021518405A5
Authority
JP
Japan
Prior art keywords
progesterone
vaginal ring
ring according
vaginal
polymorph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020550751A
Other languages
English (en)
Japanese (ja)
Other versions
JP7391863B2 (ja
JP2021518405A (ja
Filing date
Publication date
Priority claimed from EP18382190.9A external-priority patent/EP3542786A1/en
Application filed filed Critical
Publication of JP2021518405A publication Critical patent/JP2021518405A/ja
Publication of JP2021518405A5 publication Critical patent/JP2021518405A5/ja
Application granted granted Critical
Publication of JP7391863B2 publication Critical patent/JP7391863B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020550751A 2018-03-21 2019-03-21 プロゲステロン膣内デバイス Active JP7391863B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382190.9A EP3542786A1 (en) 2018-03-21 2018-03-21 Progesterone intravaginal devices
EP18382190.9 2018-03-21
PCT/EP2019/057074 WO2019180133A1 (en) 2018-03-21 2019-03-21 Progesterone intravaginal devices

Publications (3)

Publication Number Publication Date
JP2021518405A JP2021518405A (ja) 2021-08-02
JP2021518405A5 true JP2021518405A5 (https=) 2022-03-14
JP7391863B2 JP7391863B2 (ja) 2023-12-05

Family

ID=61768237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550751A Active JP7391863B2 (ja) 2018-03-21 2019-03-21 プロゲステロン膣内デバイス

Country Status (7)

Country Link
US (1) US11278491B2 (https=)
EP (2) EP3542786A1 (https=)
JP (1) JP7391863B2 (https=)
KR (1) KR102844796B1 (https=)
CN (1) CN112469392A (https=)
CA (1) CA3094420C (https=)
WO (1) WO2019180133A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3542786A1 (en) 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices
MX2021011885A (es) * 2019-03-29 2022-04-18 Juniper Pharmaceuticals Inc N/K/A Catalent Jnp Inc Anillos intravaginales segmentados de eva que contienen progesterona.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
PL2359807T3 (pl) 2008-02-04 2017-12-29 Ferring B.V. Monolityczne pierścienie dopochwowe zawierające progesteron oraz metody ich wytwarzania i stosowania
MA40473A (fr) 2014-10-22 2016-04-28 Int Partnership For Microbicides Inc Dispositifs d'administration de médicaments à base d'une silicone catalysée par du platine, et leurs procédés d'utilisation
EP3542786A1 (en) 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices

Similar Documents

Publication Publication Date Title
JP7844015B2 (ja) N4-ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
KR102587510B1 (ko) 피리딘 유도체 및 hiv 감염을 치료하기 위한 그의 용도
JP5637568B2 (ja) 固体形態および調製のためのプロセス
JP2022003062A5 (https=)
JP2017141281A5 (ja) オキシトシン/バソプレッシンV1aレセプターのアンタゴニストとしてのピロリジン誘導体を含有する医薬組成物
JP2013542261A5 (https=)
JP2017524025A5 (https=)
JP2011157386A5 (https=)
JP2021518405A5 (https=)
JP2010510210A5 (https=)
JP2015501820A5 (https=)
JP2011527333A5 (https=)
WO2019007696A1 (en) NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS
JP2018516883A5 (https=)
JP2013528187A5 (https=)
CN103402994A (zh) 作为α7NACHR调节剂的杂芳基衍生物
JP2019520344A5 (https=)
JP2015502973A5 (https=)
JP2019065009A5 (https=)
JP2013512925A5 (https=)
Chen et al. An improved and efficient process for the preparation of (+)‐cloprostenol
CN102603949A (zh) 利用低纯度乙烯基吡咯烷酮制备聚维酮k30的方法
JP2018523644A5 (https=)
RU2020131251A (ru) Интравагинальные устройства, содержащие прогестерон
RU2018134045A (ru) Пролекарства селективного модулятора рецептора прогестерона (sprm) (11.бета.,17.бета.)-17-гидрокси-11-[4-(метилсульфонил)фенил]-17-(пентафторэтил))эстра-4,9-диен-3-она